The groundbreaking approach of the medication represents a major advance in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide471928.bligblogging.com/42741113/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment